Effect of resveratrol and pterostilbene on aging and longevity

BioFactors

Volumn 44, Issue 1, 2018, Pages 69-82

  Li, Yi Rong ^a,b   Li, Shiming ^c   Lin, Chi Chien ^b,d,e  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c HUANGGANG NORMAL UNIVERSITY   (China)

^d ASIA UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

aging; healthspan; lifespan; pterostilbene; resveratrol

Indexed keywords

ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PTEROSTILBENE; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN; STILBENE DERIVATIVE;

AGING; CALORIC INTAKE; CALORIC RESTRICTION; CALORIE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; HEART PROTECTION; HUMAN; INFLAMMATION; LIFE EXTENSION; LONGEVITY; NEUROPROTECTION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TELOMERE HOMEOSTASIS; ANIMAL; CARDIOVASCULAR DISEASE; CATARACT; CELL AGING; DEGENERATIVE DISEASE; GENETICS; METABOLISM; NEOPLASM; OSTEOPOROSIS; PATHOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CATARACT; CELLULAR SENESCENCE; HUMANS; INFLAMMATION; LONGEVITY; NEOPLASMS; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; OSTEOPOROSIS; OXIDATIVE STRESS; SIRTUIN 1; STILBENES; TELOMERE HOMEOSTASIS;

EID: 85037362271     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1400     Document Type: Review

References (154)

1. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013) The hallmarks of aging. Cell 153, 1194–1217.
2. Smita, S., Lange, F., Wolkenhauer, O., and Köhling, R. (2016) Deciphering hallmark processes of aging from interaction networks. Biochim Biophys Acta 1860, 2706–2715.
3. Wahab, A., Gao, K., Jia, C., Zhang, F., Tian, G., et al. (2017) Significance of resveratrol in clinical management of chronic diseases. Molecules 22, pii: E1329.
4. Agrawal, M. (2015) Natural polyphenols based new therapeutic avenues for advanced biomedical applications. Drug Metab Rev 47, 420–430.
5. Reinisalo, M., Kårlund, A., Koskela, A., Kaarniranta, K., and Karjalainen, R. O. (2015) Polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases. Oxid Med Cell Longev 2015, 340520.
6. Guillaumet-Adkins, A., Yañez, Y., Peris-Diaz, M. D., Calabria, I., Palanca-Ballester, C., et al. (2017) Epigenetics and oxidative stress in aging. Oxid Med Cell Longev 2017, 9175806.
7. Go, Y. M., and Jones, D. P. (2017) Redox theory of aging: implications for health and disease. Clin Sci (Lond) 131, 1669–1688.
8. Salmon, A. B. (2016) Beyond diabetes: does obesity-induced oxidative stress drive the aging process?. Antioxidants (Basel) 5, pii: E24.
9. Bonet-Costa, V., Pomatto, L. C., and Davies, K. J. (2016) The proteasome and oxidative stress in alzheimer's disease. Antioxid Redox Signal 25, 886–901.
10. Robert, L., and Labat-Robert, J. (2015) Stress in biology and medicine, role in aging. Pathol Biol (Paris) 63, 230–234.
11. Novelle, M. G., Wahl, D., Diéguez, C., Bernier, M., and de Cabo, R. (2015) Resveratrol supplementation: where are we now and where should we go?. Ageing Res Rev 21, 1–15.
12. Sadowska-Bartosz, I., and Bartosz, G. (2014) Effect of antioxidants supplementation on aging and longevity. Biomed Res Int 2014, 404680.
13. Cucciolla, V., Borriello, A., Oliva, A., Galletti, P., Zappia, V. et al. (2007) Resveratrol: from basic science to the clinic. Cell Cycle 6, 2495–2510.
14. Liang, Q., Wang, X. P., and Chen, T. S. (2014) Resveratrol protects rabbit articular chondrocyte against sodium nitroprusside-induced apoptosis via scavenging ROS. Apoptosis 19, 1354–1363.
15. Toth, P., Tarantini, S., Springo, Z., Tucsek, Z., Gautam, T., et al. (2015) Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell 14, 400–408.
16. Tang, Y., Xu, J., Qu, W., Peng, X., Xin, P., et al. (2012) Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. J Nutr Biochem 23,1410–1416.
17. Ido, Y., Duranton, A., Lan, F., Weikel, K. A., Breton, L., et al. (2015) Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. PLoS One 10, e0115341.
18. Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., et al. (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106, 383–389.
19. Olas, B., Nowak, P., and Wachowicz, B. (2004) Resveratrol protects against peroxynitrite-induced thiol oxidation in blood platelets. Cell Mol Biol Lett 9, 577–587.
20. Ryan, M. J., Jackson, J. R., Hao, Y., Williamson, C. L., Dabkowski, E. R., et al. (2010) Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J Gerontol A Biol Sci Med Sci 65, 815–831.
21. Movahed, A., Yu, L., Thandapilly, S. J., Louis, X. L., and Netticadan, T. (2012) Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury. Arch Biochem Biophys 527, 74–80.
22. Zhou, X., Chen, M., Zeng, X., Yang, J., Deng, H., et al. (2014) Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells. Cell Death Dis 5, e1576.
23. Tung, B. T., Rodríguez-Bies, E., Ballesteros-Simarro, M., Motilva, V., Navas, P., et al. (2014) Modulation of endogenous antioxidant activity by resveratrol and exercise in mouse liver is age dependent. J Gerontol A Biol Sci Med Sci 69, 398–409.
24. Mukherjee, S., Dudley, J. I., and Das, D. K. (2010) Dose-dependency of resveratrol in providing health benefits. Dose Response 8, 478–500.
25. de la Lastra, C. A., and Villegas, I. (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35, 1156–1160.
26. Candore, G., Caruso, C., and Colonna-Romano, G. (2010) Inflammation, genetic background and longevity. Biogerontology 11, 565–573.
27. Tung, B. T., Rodríguez-Bies, E., Talero, E., Gamero-Estévez, E., Motilva, V., et al. (2015) Anti-inflammatory effect of resveratrol in old mice liver. Exp Gerontol 64, 1–7.
28. Jeong, S. I., Shin, J. A., Cho, S., Kim, H. W., Lee, J. Y., et al. (2016) Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice. Neurobiol Aging 44, 74–84.
29. Subedi, L., Lee, T. H., Wahedi, H. M., Baek, S. H., and Kim, S. Y. (2017) Resveratrol-enriched rice attenuates UVB-ROS-induced skin aging via downregulation of inflammatory cascades. Oxid Med Cell Longev 2017, 8379539.
30. Tomé-Carneiro, J., Larrosa, M., Yáñez-Gascón, M. J., Dávalos, A., Gil-Zamorano, J., et al. (2013) One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res 72, 69–82.
31. Bo, S., Ciccone, G., Castiglione, A., Gambino, R., De Michieli, F., et al. (2013) Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem 20, 1323–1331.
32. Chekalina, N. I., Kazakov, Y. M., Mamontova, T. V., Vesnina, L. E., and Kaidashev, I. P. (2016) Resveratrol more effectively than quercetin reduces endothelium degeneration and level of necrosis factor α in patients with coronary artery disease. Wiad Lek 69, 475–479.
33. Omodei, D., and Fontana, L. (2011) Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 585, 1537–1542.
34. Marchal, J., Blanc, S., Epelbaum, J., Aujard, F., and Pifferi, F. (2012) Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus. PLoS One 7, e34289.
35. Guo, X. F., Li, J. M., Tang, J., and Li, D. (2017) Effects of resveratrol supplementation on risk factors of non-communicable diseases: a meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 1–15.
36. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612–622.
37. Dolinsky, V. W., and Dyck, J. R. (2011) Calorie restriction and resveratrol in cardiovascular health and disease. Biochim Biophys Acta 1812, 1477–1489.
38. Stockinger, J., Maxwell, N., Shapiro, D., deCabo, R., and Valdez, G. (2017) Caloric restriction mimetics slow aging of neuromuscular synapses and muscle fibers. J Gerontol A Biol Sci Med Sci. [Epub ahead of print]
39. Rizvi, S., Raza, S. T., and Mahdi, F. (2014) Telomere length variations in aging and age-related diseases. Curr Aging Sci 7, 161–167.
40. Uchiumi, F., Watanabe, T., Hasegawa, S., Hoshi, T., Higami, Y., et al. (2011) The effect of resveratrol on the Werner syndrome RecQ helicase gene and telomerase activity. Curr Aging Sci 4, 1–7.
41. Wang, X. B., Zhu, L., Huang, J., Yin, Y. G., Kong, X. Q., et al. J. (2011) Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells. Chin Med J (Engl) 124, 4310–4315.
42. Huang, P., Riordan, S. M., Heruth, D. P., Grigoryev, D. N., Zhang, L. Q., et al. (2015) A critical role of nicotinamide phosphoribosyltransferase in human telomerase reverse transcriptase induction by resveratrol in aortic smooth muscle cells. Oncotarget 6, 10812–10824.
43. Acharya, J. D., and Ghaskadbi, S. S. (2013) Protective effect of pterostilbene against free radical mediated oxidative damage. BMC Complement Altern Med 13, 238. 26
44. Wang, B., Liu, H., Yue, L., Li, X., Zhao, L., et al. (2016) Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway. Brain Res 1643, 70–79.
45. Yang, Y., Fan, C., Wang, B., Ma, Z., Wang, D., et al. (2017) Pterostilbene attenuates high glucose-induced oxidative injury in hippocampal neuronal cells by activating nuclear factor erythroid 2-related factor 2. Biochim Biophys Acta 1863, 827–837.
46. Li, J., Deng, R., Hua, X., Zhang, L., Lu, F., et al. Q. (2016) Blueberry component pterostilbene protects corneal epithelial cells from inflammation via anti-oxidative pathway. Sci Rep 6, 19408.
47. Dos Santos Lacerda, D., Türck, P., Gazzi de Lima-Seolin, B., Colombo, R., Duarte Ortiz, V., et al. (2017) Pterostilbene reduces oxidative stress, prevents hypertrophy and preserves systolic function of right ventricle in cor pulmonale model. Br J Pharmacol 174, 3302–3314.
48. Sirerol, J. A., Feddi, F., Mena, S., Rodriguez, M. L., Sirera, P., et al. (2015) Topical treatment with pterostilbene, a natural phytoalexin, effectively protects hairless mice against UVB radiation-induced skin damage and carcinogenesis. Free Radic Biol Med 85, 1–11.
49. Kosuru, R., and Singh, S. (2017) Pterostilbene ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats. Life Sci 182, 112–121.
50. Qureshi, A. A., Khan, D. A., Mahjabeen, W., Papasian, C. J., and Qureshi, N. (2012) Suppression of nitric oxide production and cardiovascular risk factors in healthy seniors and hypercholesterolemic subjects by a combination of polyphenols and vitamins. J Clin Exp Cardiolog S5, 8.
51. Hou, Y., Xie, G., Miao, F., Ding, L., Mou, Y., et al. (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuropsychopharmacol Biol Psychiatry 54, 92–102.
52. Hsu, C. L., Lin, Y. J., Ho, C. T., and Yen, G. C. (2013) The inhibitory effect of pterostilbene on inflammatory responses during the interaction of 3T3-L1 adipocytes and RAW 264.7 macrophages. J Agric Food Chem 61, 602–610.
53. Choo, Q. Y., Yeo, S. C. M., Ho, P. C., Tanaka, Y., and Lin, H. S. (2014) Pterostilbene surpassed resveratrol for anti-inflammatory application: potency consideration and pharmacokinetics perspective. J Funct Foods 11, 352–362.
54. Xue, E. X., Lin, J. P., Zhang, Y., Sheng, S. R., Liu, H. X., et al. (2017) Pterostilbene inhibits inflammation and ROS production in chondrocytes by activating Nrf2 pathway. Oncotarget 8, 41988–42000.
55. Sireesh, D., Ganesh, M. R., Dhamodharan, U., Sakthivadivel, M., Sivasubramanian, S., et al. (2017) Role of pterostilbene in attenuating immune mediated devastation of pancreatic beta cells via Nrf2 signaling cascade. J Nutr Biochem 44, 11–21.
56. Hou, Y., Li, N., Xie, G., Wang, J., Yuan, Q., et al. (2015) Pterostilbene exerts anti-neuroinflammatory effect on lipopolysaccharide-activated microglia via inhibition of MAPK signalling pathways. J Funct Foods 19, 676–687.
57. Liu, X., Yang, X., Han, L., Ye, F., Liu, M., et al. (2017) Pterostilbene alleviates polymicrobial sepsis-induced liver injury: possible role of SIRT1 signaling. Int Immunopharmacol 49, 50–59.
58. Li, D., Song, T., Yang, L., Wang, X., Yang, C., et al. (2016) Neuroprotective actions of pterostilbene on hypoxic-ischemic brain damage in neonatal rats through upregulation of heme oxygenase-1. Int J Dev Neurosci 54, 22–31.
59. Ono-Moore, K. D., Snodgrass, R. G., Huang, S., Singh, S., Freytag, T. L., et al. (2016) Postprandial inflammatory responses and free fatty acids in plasma of adults who consumed a moderately high-fat breakfast with and without blueberry powder in a randomized placebo-controlled trial. J Nutr 146, 1411–1419.
60. Johnson, S. A., Feresin, R. G., Navaei, N., Figueroa, A., Elam, M. L., et al. (2017) Effects of daily blueberry consumption on circulating biomarkers of oxidative stress, inflammation, and antioxidant defense in postmenopausal women with pre- and stage 1-hypertension: a randomized controlled trial. Food Funct 8, 372–380.
61. Zhong, Y., Wang, Y., Guo, J., Chu, H., Gao, Y., et al. (2015) Blueberry improves the therapeutic effect of etanercept on patients with juvenile idiopathic arthritis: phase III study. Tohoku J Exp Med 237, 183–191.
62. Kasiotis, K. M., Pratsinis, H., Kletsas, D., and Haroutounian, S. A. (2013) Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol 61, 112–120.
63. McCormack, D., and McFadden, D. (2013) A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev 2013, 575482.
64. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., et al. (2003) mall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191–196.
65. Collins, J. J., Evason, K., and Kornfeld, K. (2006) Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans. Exp Gerontol 41, 1032–1039.
66. Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., and Partridge, L. (2007) Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 128, 546–552.
67. Wang, C., Wheeler, C. T., Alberico, T., Sun, X., Seeberger, J., et al. (2013) The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age 35, 69–81. (Dordr).
68. Rascón, B., Hubbard, B. P., Sinclair, D. A., and Amdam, G. V. (2012) The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction. Aging 4, 499–508. (Albany NY).
69. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., et al. (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 16, 296–300.
70. Kim, E., Ansell, C. M., and Dudycha, J. L. (2014) Resveratrol and food effects on lifespan and reproduction in the model crustacean Daphnia. J Exp Zool A Ecol Genet Physiol 321, 48–56.
71. Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., et al. (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157–168.
72. Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., et al. (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66, 191–201.
73. Strong, R., Miller, R. A., Astle, C. M., Baur, J. A., de Cabo, R., et al. (2013) Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 68, 6–16.
74. Fernández, A. F., and Fraga, M. F. (2011) The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics 6, 870–874.
75. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342.
76. Gerhardt, E., Gräber, S., Szego, E. M., Moisoi, N., Martins, L. M., et al. (2011) Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PLoS One 6, e28855.
77. Mancuso, R., del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., et al. (2014) Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics 11, 419–432.
78. Klink, J. C., Tewari, A. K., Masko, E. M., Antonelli, J., Febbo, P. G., et al. (2013) Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. Prostate 73, 754–762.
79. Wilson, M. A., Shukitt-Hale, B., Kalt, W., Ingram, D. K., Joseph, J. A., et al. (2006) Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 5, 59–68.
80. Peng, C., Zuo, Y., Kwan, K. M., Liang, Y., Ma, K. Y., et al. (2012) Blueberry extract prolongs lifespan of Drosophila melanogaster. Exp Gerontol 47, 170–178.
81. Perecko, T., Drabikova, K., Rackova, L., Ciz, M., Podborska, M., et al. (2010) Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro. Neuro Endocrinol Lett 31(Suppl 2), 84–90.
82. Chen, W., Rezaizadehnajafi, L., and Wink, M. (2013) Influence of resveratrol on oxidative stress resistance and life span in Caenorhabditis elegans. J Pharm Pharmacol 65, 682–688.
83. Ye, K., Ji, C. B., Lu, X. W., Ni, Y. H., Gao, C. L., et al. (2010) Resveratrol attenuates radiation damage in Caenorhabditis elegans by preventing oxidative stress. J Radiat Res 51, 473–479.
84. Yin, H., Si, J., Xu, H., Dong, J., Zheng, D., et al. (2014) Resveratrol-loaded nanoparticles reduce oxidative stress induced by radiation or amyloid-beta in transgenic Caenorhabditis elegans. J Biomed Nanotechnol 10, 1536–1544.
85. He, Q., Li, Z., Wang, Y., Hou, Y., Li, L., et al. (2017) Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction. Int Immunopharmacol 50, 208–215. Sep
86. Abdel-Aleem, G. A., Khaleel, E. F., Mostafa, D. G., and Elberier, L. K. (2016) Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway. Arch Physiol Biochem 122, 200–213.
87. Li, Z., Fang, F., Wang, Y., and Wang, L. (2016) Resveratrol protects CA1 neurons against focal cerebral ischemic reperfusion-induced damage via the ERK-CREB signaling pathway in rats. Pharmacol Biochem Behav 146–147, 21–27.
88. Meng, Z., Li, J., Zhao, H., Liu, H., Zhang, G., et al. (2015) Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1. Exp Ther Med 10, 525–530.
89. Wei, H., Wang, S., Zhen, L., Yang, Q., Wu, Z., et al. (2015) Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats. J Mol Neurosci 55, 872–879.
90. Singh, N., Agrawal, M., and Doré, S. (2013) Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem Neurosci 4, 1151–1162.
91. Feng, Y., Wang, X. P., Yang, S. G., Wang, Y. J., Zhang, X., et al. (2009) Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 30, 986–995.
92. Porat, Y., Abramowitz, A., and Gazit, E. (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67, 27–37.
93. Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., et al. (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 285, 9100–9113.
94. Maher, P., Dargusch, R., Bodai, L., Gerard, P. E., Purcell, J. M., et al. (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum Mol Genet 20, 261–270.
95. Song, L., Chen, L., Zhang, X., Li, J., and Le, W. (2014) Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Biomed Res Int 2014, 483501.
96. Sawda, C., Moussa, C., and Turner, R. S. (2017) Resveratrol for Alzheimer's disease. Ann N Y Acad Sci 1403, 142–149. Sep
97. Witte, A. V., Kerti, L., Margulies, D. S., and Flöel, A. (2014) Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci 4;34, 7862–7870.
98. Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., et al. (2010) Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 91, 1590–1597.
99. Wightman, E. L., Reay, J. L., Haskell, C. F., Williamson, G., Dew, T. P., et al. (2014) Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. Br J Nutr 112, 203–213. 28
100. Song, Z., Han, S., Pan, X., Gong, Y., and Wang, M. (2015) Pterostilbene mediates neuroprotection against oxidative toxicity via oestrogen receptor α signalling pathways. J Pharm Pharmacol 67, 720–730.
101. Chang, J., Rimando, A., Pallas, M., Camins, A., Porquet, D., et al. (2012) Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiol Aging 33, 2062–2071. Sep
102. Bhatt, S. R., Lokhandwala, M. F., and Banday, A. A. (2011) Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol 667, 258–264.
103. Natalin, H. M., Garcia, A. F., Ramalho, L. N., and Restini, C. B. (2016) Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension. Cardiovasc Pathol 25, 116–119.
104. Dolinsky, V. W., Chakrabarti, S., Pereira, T. J., Oka, T., Levasseur, J., et al. (2013) Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim Biophys Acta 1832, 1723–1733.
105. Yu, L., Tu, Y., Jia, X., Fang, K., Liu, L., et al. (2017) Resveratrol protects against pulmonary arterial hypertension in rats via activation of silent information regulator 1. Cell Physiol Biochem 42, 55–67.
106. Bradamante, S., Barenghi, L., Piccinini, F., Bertelli, A. A., De Jonge, R., et al. (2003) Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 465, 115–123.
107. Yang, Q., Wang, H. C., Liu, Y., Gao, C., Sun, L., et al. (2016) Resveratrol cardioprotection against myocardial ischemia/reperfusion injury involves upregulation of adiponectin levels and multimerization in Type 2 Diabetic Mice. J Cardiovasc Pharmacol 68, 304–312.
108. Cheng, L., Jin, Z., Zhao, R., Ren, K., Deng, C., et al. (2015) Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int J Clin Exp Med 8, 10420–10428.
109. Yang, L., Zhang, Y., Zhu, M., Zhang, Q., Wang, X., et al. (2016) Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B. Free Radic Biol Med 101, 1–9.
110. Das, D. K., and Maulik, N. (2006) Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 6, 36–47.
111. Zordoky, B. N., Robertson, I. M., and Dyck, J. R. (2015) Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta 1852, 1155–1177.
112. Dolinsky, V. W., Soltys, C. L., Rogan, K. J., Chan, A. Y., Nagendran, J., et al. R. (2015) Resveratrol prevents pathological but not physiological cardiac hypertrophy. J Mol Med 93, 413–425. (Berl).
113. Kanamori, H., Takemura, G., Goto, K., Tsujimoto, A., Ogino, A., et al. (2013) Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am J Pathol 182, 701–713.
114. Gu, X. S., Wang, Z. B., Ye, Z., Lei, J. P., Li, L., et al. (2014) Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. Genet Mol Res 13, 323–335.
115. Magyar, K., Halmosi, R., Palfi, A., Feher, G., Czopf, L., et al. (2012) Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc 50, 179–187.
116. Militaru, C., Donoiu, I., Craciun, A., Scorei, I. D., Bulearca, A. M., et al. (2013) Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life. Nutrition 29, 178–183.
117. Rimando, A. M., Nagmani, R., Feller, D. R., and Yokoyama, W. (2005) Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem 53, 3403–3407.
118. Zhang, L., Zhou, G., Song, W., Tan, X., Guo, Y., et al. (2012) Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo. Apoptosis 17, 25–36.
119. Zhang, L., Cui, L., Zhou, G., Jing, H., Guo, Y., et al. (2013) Pterostilbene, a natural small-molecular compound, promotes cytoprotective macroautophagy in vascular endothelial cells. J Nutr Biochem 24, 903–911.
120. Wu, M., Lu, S., Zhong, J., Huang, K., and Zhang, S. (2017) Protective effects of pterostilbene against myocardial ischemia/reperfusion injury in rats. Inflammation 40, 578–588.
121. Yu, Z., Wang, S., Zhang, X., Li, Y., Zhao, Q., et al. (2017) Pterostilbene protects against myocardial ischemia/reperfusion injury via suppressing oxidative/nitrative stress and inflammatory response. Int Immunopharmacol 43, 7–15.
122. Lv, M., Liu, K., Fu, S., Li, Z., and Yu, X. (2015) Pterostilbene attenuates the inflammatory reaction induced by ischemia/reperfusion in rat heart. Mol Med Rep 11, 724–728.
123. Guo, Y., Zhang, L., Li, F., Hu, C. P., and Zhang, Z. (2016) Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes. Eur J Pharmacol 776, 26–33.
124. Estrela, J. M., Ortega, A., Mena, S., Rodriguez, M. L., and Asensi, M. (2013) Pterostilbene: biomedical applications. Crit Rev Clin Lab Sci 50, 65–78.
125. Szkudelski, T., and Szkudelska, K. (2015) Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta 1852, 1145–1154.
126. Szkudelska, K., and Szkudelski, T. (2010) Resveratrol, obesity and diabetes. Eur J Pharmacol 635, 1–8.
127. Movahed, A., Nabipour, I., Lieben Louis, X., Thandapilly, S. J., Yu, Let al. (2013) Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid Based Complement Alternat Med 2013, 851267.
128. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., et al. (2012) Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67, 1307–1312.
129. Chachay, V. S., Macdonald, G. A., Martin, J. H., Whitehead, J. P., O'Moore-Sullivan, T. M., et al. (2014) Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 12, 2092–2103.e1–6.
130. Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., et al. (2013) High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186–1195.
131. Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S., et al. (2012) Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16, 658–664.
132. Bhakkiyalakshmi, E., Shalini, D., Sekar, T. V., Rajaguru, P., Paulmurugan, R., et al. (2014) Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2. Br J Pharmacol 171, 1747–1757.
133. Pari, L., and Satheesh, M. A. (2006) Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats. Life Sci 79, 641–645.
134. Elango, B., Dornadula, S., Paulmurugan, R., and Ramkumar, K. M. (2016) Pterostilbene ameliorates streptozotocin-induced diabetes through enhancing antioxidant signaling pathways mediated by Nrf2. Chem Res Toxicol 29, 47–57. 19
135. Kaeberlein, M., McVey, M., and Guarente, L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13, 2570–2580.
136. Bordone, L., and Guarente, L. (2005) Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6, 298–305.
137. Dali-Youcef, N., Lagouge, M., Froelich, S., Koehl, C., Schoonjans, K., et al (2007) Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med 39, 335–345.
138. Al-Regaiey, K. A. (2016) The effects of calorie restriction on aging: a brief review. Eur Rev Med Pharmacol Sci 20, 2468–2473.
139. Ran, G., Ying, L., Li, L., Yan, Q., Yi, W., et al. (2017) Resveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio rerio). PLoS One 12, e0180865.
140. Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., et al. H. (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421–433.
141. Renes, J., Rosenow, A., Roumans, N., Noben, J. P., and Mariman, E. C. (2014) Calorie restriction-induced changes in the secretome of human adipocytes, comparison with resveratrol-induced secretome effects. Biochim Biophys Acta 1844, 1511–1522. Sep
142. Das, S., Mitrovsky, G., Vasanthi, H. R., and Das, D. K. (2014) Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev 2014, 345105.
143. Cheng, Y., Di, S., Fan, C., Cai, L., Gao, C., et al. (2016) SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury. Apoptosis 21, 905–916.
144. Salminen, A., Kaarniranta, K., and Kauppinen, A. (2016) Age-related changes in AMPK activation: role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Res Rev 28, 15–26.
145. Burkewitz, K., Weir, H. J., and Mair, W. B. (2016) AMPK as a pro-longevity target. EXS 107, 227–256.
146. Ruiz, R., Pérez-Villegas, E. M., and Manuel Carrión, Á. (2016) AMPK function in aging process. Curr Drug Targets 17, 932–941.
147. Sun, G. Q., Li, Y. B., Du, B., and Meng, Y. (2015) Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice. Clin Exp Hypertens 37, 616–621.
148. Thompson, A. M., Martin, K. A., and Rzucidlo, E. M. (2014) Resveratrol induces vascular smooth muscle cell differentiation through stimulation of SirT1 and AMPK. PLoS One 9, e85495.
149. Qin, N., Wei, L., Li, W., Yang, W., Cai, L., et al. (2017) Local intra-articular injection of resveratrol delays cartilage degeneration in C57BL/6 mice by inducing autophagy via AMPK/mTOR pathway. J Pharmacol Sci 134, 166–174.
150. Liu, X. F., Hao, J. L., Xie, T., Malik, T. H., Lu, C. B., et al. (2017) Nrf2 as a target for prevention of age-related and diabetic cataracts by against oxidative stress. Aging Cell 16, 934–942.
151. Narasimhan, M., and Rajasekaran, N. S. (2016) Exercise, Nrf2 and antioxidant signaling in cardiac aging. Front Physiol 7, 241.
152. Swamy, S. M., Rajasekaran, N. S., and Thannickal, V. J. (2016) Nuclear factor-erythroid-2-related factor 2 in aging and lung fibrosis. Am J Pathol 186, 1712–1723.
153. Li, H., Jiang, N., Liang, B., Liu, Q., Zhang, E., et al. (2017) Pterostilbene protects against UVB-induced photo-damage through a phosphatidylinositol-3-kinase-dependent Nrf2/ARE pathway in human keratinocytes. Redox Rep 22, 1–7.
154. Bhakkiyalakshmi, E., Sireesh, D., Sakthivadivel, M., Sivasubramanian, S., Gunasekaran, P., et al. (2016) Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes. Eur J Pharmacol 777, 9–16. 15